emerged as therapeutic candidate for Alzheimer's disease (AD). However, intravenous
CNPs are limited due to their poor physicochemical properties, rapid blood clearance and
poor blood–brain penetration. Thus, we developed intranasal CNPs and evaluated its
potential in experimental AD. CNPs were synthesized using homogenous precipitation
method and optimized through Box–Behnken Design. The formation of CNPs was confirmed …